Bay Area's Arcus Biosciences Scores $107M, Initiates Two Clinical Trials Post author:Sam Post published:November 12, 2017 Post category:BioPharma Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing. Source: BioSpace You Might Also Like Philips to Move North American HQ and Its 2,000 Employees to Cambridge January 11, 2018 SoCal's Artelo Biosciences Inks $202M+ R&D Deal With the NEOMED Institute January 29, 2018 Merck KGaA, Pfizer's Bavencio Flunks Late-Stage Gastric Cancer Trial November 27, 2017